Teneligliptin Hydrobromide Hydrate

Teneligliptin Hydrobromide Hydrate(MP-513 hydrobromide hydrate) is a potent, competitive, and long-lasting inhibitor of DPP-4. It competitively inhibited rhDPP-4, human plasma, and rat plasma with IC50 values of 0.889, 1.75, and 1.35 nM respectively. It suppresses high glucose-mediated mitochondrial dysfunction and can be used for treatment of type 2 diabetes.

Trivial name MP-513 hydrobromide hydrate
Catalog Number E4814
Molecular Formula C28H30CIN5O4S
CAS# 1572583-29-9
Inchi InChI=1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37,38)33(4)20-7-5-6-19(29)14-20/h5-9,14-16,30H,10-13H2,1-4H3,(H,31,35)/b23-16-
Inchi Key FPYJSJDOHRDAMT-KQWNVCNZSA-N
SMILES CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)C=C3C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O
Size 1g
Supplier Page http://www.selleckchem.com/products/teneligliptin-hydrobromide-hydrate.html
Additional Information https://file.selleck.cn/downloads/struct/E4814-Teneligliptin-Hydrobromide-Hydrate-chemical-structure.png